NCT04102410

Brief Summary

Cardiac rehabilitation includes aerobic and anaerobic training adapted to cardiovascular pathology for which cardiac rehabilitation is prescribed. It is essential to adapt the content of these cardiac rehabilitation sessions to optimize aerobic and anaerobic performance and quality of life. Improvement of the first ventilatory threshold is one of the main objectives since it illustrates the adaptation of the patient to submaximal exercise, typical of everyday life. The research laboratory "Autonomous Nervous System - Epidemiology, Physiology, Engineering, Health" (SPA-EPIS) has an international expertise in training optimization in top-athletes. He have shown the importance of the relationship between the power-force-velocity profile and athletes performances.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 25, 2019

Completed
5 days until next milestone

Study Start

First participant enrolled

September 30, 2019

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 4, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 4, 2022

Completed
Last Updated

June 3, 2022

Status Verified

June 1, 2022

Enrollment Period

2.5 years

First QC Date

September 23, 2019

Last Update Submit

June 2, 2022

Conditions

Keywords

Cardiac rehabilitationPhysical activityForce-velocity profileAutonomic nervous systemCoronary artery disease

Outcome Measures

Primary Outcomes (1)

  • volume of oxygen consumed (VO2) (in ml/min/kg) at the first ventilatory threshold (SV1)

    Change in VO2 (volume of oxygen in ml/min/kg) at the first ventilatory threshold (SV1) during a Cardio-Pulmonary Exercise Test (CPET).

    Months: 0 and 2

Secondary Outcomes (12)

  • VO2 max (volume of oxygen maximum in ml/min/kg)

    Months: 0 and 2

  • Power at first ventilatory threshold (SV1)

    Months: 0 and 2

  • Maximum aerobic power (in watt)

    Months: 0 and 2

  • Voluntary muscle power (in kg) during a static muscle testing on quadriceps

    Months: 0 and 2

  • Voluntary muscle power (in kg) during a dynamic muscle testing on quadriceps

    Months: 0 and 2

  • +7 more secondary outcomes

Study Arms (2)

Experimental group

EXPERIMENTAL

Patient with acute coronary syndrome will be included. They will have sprints, vertical jumps, questionary Short Form-12 (SF-12), activity actigraph and program composed of two 2 training strategies.

Other: SprintsOther: Vertical jumpsOther: Questionary Short Form-12 (SF-12)Device: activity actigraphOther: Program composed of two 2 training strategies

Control group

SHAM COMPARATOR

Patient with acute coronary syndrome will be included. They will have sprints, vertical jumps, questionary Short Form-12 (SF-12), activity actigraph and program of usual practice.

Other: SprintsOther: Vertical jumpsOther: Questionary Short Form-12 (SF-12)Device: activity actigraphOther: Program of usual practice

Interventions

SprintsOTHER

Two sprints of 8 seconds on a cycle ergometer will be performed for determine Force/Velocity Profile (FVP). Realized at inclusion and 2 months after.

Control groupExperimental group

Two vertical jumps will be performed. Height of theses vertical jumps will be measured by application "My jump 2" to determine muscle power. Realized at inclusion and 2 months after.

Control groupExperimental group

Questionary Short Form-12 (SF-12) will be performed to evaluate quality of life. It is composed of 12 questions. Realized at inclusion and 2 months after.

Control groupExperimental group

Activity actigraph will be wearing by patient during 7 consecutive days. It measures the level of physical activity and the sedentary lifestyle of patients. Realized at inclusion and 2 months after.

Also known as: Wristlet connected
Control groupExperimental group

Program composed of two 2 training strategies according to the initial Force/Velocity Profile (FVP) will be realized at the inclusion. There are : * Strategy "experimental-speed": speed training strategy for subjects with a force-speed profile (PFV) in favour of force * Strategy "experimental-force": force training strategy for subjects with a force-speed profile (PFV) in favour of speed.

Experimental group

Program composed of training in force and speed independently of the initial Force/Velocity Profile (FVP).

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Acute coronary syndrome treated within the last 6 months
  • Medical revascularization (angioplasty ± stenting) or surgical (coronary artery bypass)
  • During initial effort test: Maximum aerobic power≥ 60 watts for women and ≥ 80 watts for men
  • Patient affiliated or beneficiary to social security
  • Signed informed consent

You may not qualify if:

  • Significant co-morbidities limited practice of physical activity
  • Inability to submit to medical monitoring of the program
  • Patient deprived of liberty or patient under guardianship
  • Pregnant woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Saint-Etienne

Saint-Etienne, France

Location

MeSH Terms

Conditions

Acute Coronary SyndromeMotor ActivityCoronary Artery Disease

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesBehaviorCoronary DiseaseArteriosclerosisArterial Occlusive Diseases

Study Officials

  • David HUPIN, MD

    CHU SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2019

First Posted

September 25, 2019

Study Start

September 30, 2019

Primary Completion

April 4, 2022

Study Completion

April 4, 2022

Last Updated

June 3, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations